Ironwood Pharma's market cap is currently $251.77M. The company's EPS TTM is $0.14; its P/E ratio is 85.74; Ironwood Pharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
